FDA Draft Attempts To Fill Gap From Expired Off-Label Distribution Reg

A draft 1guidance spelling out the circumstances under which manufacturers can distribute journal article reprints describing off-label uses of their products may offer a little more leeway, but it is not expected to have a major impact on oversight of marketing practices, industry lawyers say